Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001019687-15-004177
Filing Date
2015-11-17
Accepted
2015-11-17 09:06:48
Documents
11
Period of Report
2015-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT cannabics_10qa-053115.htm 10-Q/A 180934
2 CERTIFICATION cannabics_10qa-3101.htm EX-31.1 9132
3 CERTIFICATION cannabics_10qa-3102.htm EX-31.2 9150
4 CERTIFICATION cannabics_10qa-3201.htm EX-32.1 5083
5 CERTIFICATION cannabics_10qa-3202.htm EX-32.2 5033
  Complete submission text file 0001019687-15-004177.txt   990263

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20150531.xml EX-101.INS 82222
7 XBRL SCHEMA FILE cnbx-20150531.xsd EX-101.SCH 13607
8 XBRL CALCULATION FILE cnbx-20150531_cal.xml EX-101.CAL 27632
9 XBRL DEFINITION FILE cnbx-20150531_def.xml EX-101.DEF 11888
10 XBRL LABEL FILE cnbx-20150531_lab.xml EX-101.LAB 109790
11 XBRL PRESENTATION FILE cnbx-20150531_pre.xml EX-101.PRE 77059
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-52403 | Film No.: 151237153
SIC: 1000 Metal Mining